Moderna, Inc. vs PAGSEG Inc — how do they compare? Moderna, Inc. trades at $59.72 (market cap $23.60B), while PAGSEG Inc trades at $9.61 (market cap $2.60B). The key difference: Moderna, Inc. is far larger — about 9.1× PAGSEG Inc's market cap, and PAGSEG Inc pays a 11.19% dividend while Moderna, Inc. pays none. Which is the better fit depends on your goals.
| MRNA | PAGS | |
|---|---|---|
Market Cap | $23.60B | $2.60B |
Sector | Health | Technology |
52-Week High | $81.80 | $12.00 |
52-Week Low | $22.36 | $7.75 |
Enterprise Value | $19.70B | $10.23B |
Dividend Yield | — | 11.19% |
Trailing returns across standard periods
Latest headlines on both assets
Moderna, Inc. operates as a clinical stage biotechnology company. The Company focuses on the discovery and development of messenger RNA (mRNA) therapeutics and vaccines. Moderna develops mRNA medicines for infectious, immuno-oncology, and cardiovascular diseases.
Read more on MRNA →PagSeguro Digital Ltd. is a leading provider of financial technology solutions in Brazil, primarily focused on e-commerce, face-to-face transactions, and financial services. The company's main offerings include PagBank, a digital banking platform, and PagSeguro, a suite of payment processing solutions that includes point-of-sale devices and online payment gateways. PAGS targets micro-merchants, small and medium-sized enterprises (SMEs), and consumers, aiming to democratize access to financial services in the country.
Read more on PAGS →